Loading organizations...
Curiox Biosystems is a Seoul, South Korea-based company that develops and manufactures centrifuge-free automation technologies for cell analysis workflows in the life sciences and drug discovery sectors. The company's proprietary C-FREE platform, which includes the Laminar Wash and Pluto systems, utilizes controlled laminar flow to gently wash cells and improve reproducibility by replacing traditional centrifugation methods. Operating globally with additional facilities in the United States, Singapore, and Europe, the firm supplies automated equipment and consumables to academic laboratories and multinational pharmaceutical corporations, including Pfizer and Takeda. Curiox Biosystems currently operates with a workforce of approximately 52 employees and is publicly traded on the KOSDAQ exchange under the ticker symbol 445680. The organization was originally founded in Singapore in 2008 by Namyong Kim before relocating its corporate headquarters to Seoul, South Korea in 2018.
Curiox Biosystems has raised $30.0M across 2 funding rounds.
Curiox Biosystems has raised $30.0M in total across 2 funding rounds.
Curiox Biosystems has raised $30.0M across 2 funding rounds. Most recently, it raised $15.0M Series C in March 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 16, 2022 | $15M Series C | LEE Jong Hoon | KB Investment, Quad Investment Management | Announced |
| Oct 16, 2019 | $15M Series B | — | DAYLI Investment, HB Investment, Aleum LEE, KB Investment, Quad Investment Management, SV Investment | Announced |
Curiox Biosystems has raised $30.0M in total across 2 funding rounds.
Curiox Biosystems's investors include Lee Jong-hoon, KB Investment, QUAD Investment Management, DAYLI Investment, HB Investment, Aleum Lee, SV Investment.
